[
  {
    "ts": null,
    "headline": "Drugmakers Avoid Worst-Case Pricing Scenario for Now",
    "summary": "An executive order says if companies and the government don’t align on tying U.S. drug prices to other countries, the administration will impose its own plan.",
    "url": "https://finnhub.io/api/news?id=39a3ae92fe99bca9066d33b1482b97f912e2856b235859ee26b0084e560f4cbf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747088040,
      "headline": "Drugmakers Avoid Worst-Case Pricing Scenario for Now",
      "id": 134409250,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "An executive order says if companies and the government don’t align on tying U.S. drug prices to other countries, the administration will impose its own plan.",
      "url": "https://finnhub.io/api/news?id=39a3ae92fe99bca9066d33b1482b97f912e2856b235859ee26b0084e560f4cbf"
    }
  },
  {
    "ts": null,
    "headline": "Health Care Climbs After Trump Order Alleviates Price-Cap Fears - Health Care Roundup",
    "summary": "Health Care Climbs After Trump Order Alleviates Price-Cap Fears - Health Care Roundup",
    "url": "https://finnhub.io/api/news?id=3f5b0d974aaded4640d624b21d34c364d96143af3bac0bc46e31cc0a73cf703f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747070400,
      "headline": "Health Care Climbs After Trump Order Alleviates Price-Cap Fears - Health Care Roundup",
      "id": 134405934,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Health Care Climbs After Trump Order Alleviates Price-Cap Fears - Health Care Roundup",
      "url": "https://finnhub.io/api/news?id=3f5b0d974aaded4640d624b21d34c364d96143af3bac0bc46e31cc0a73cf703f"
    }
  },
  {
    "ts": null,
    "headline": "Drug wars: Wall Street says big questions remain about impact of Trump's new pricing order",
    "summary": "Trump signed a new executive order Monday that would attempt to force drugmakers to lower pricing in the US compared to other developed nations.",
    "url": "https://finnhub.io/api/news?id=38b8b54a72fc5416372f7fd968c63e89179bca2e547813060953f9d149dde7b7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747067695,
      "headline": "Drug wars: Wall Street says big questions remain about impact of Trump's new pricing order",
      "id": 134408773,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Trump signed a new executive order Monday that would attempt to force drugmakers to lower pricing in the US compared to other developed nations.",
      "url": "https://finnhub.io/api/news?id=38b8b54a72fc5416372f7fd968c63e89179bca2e547813060953f9d149dde7b7"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb, Sanofi Enter $700 Million Settlement With Hawaii in Plavix Lawsuit",
    "summary": "Bristol-Myers Squibb (BMY) and three US-based units of Sanofi (SNY) have reached a settlement for $7",
    "url": "https://finnhub.io/api/news?id=51f948df25d03f54d6223f156bd21005750d3daf53a4b718c338fd053609a55e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747057110,
      "headline": "Bristol-Myers Squibb, Sanofi Enter $700 Million Settlement With Hawaii in Plavix Lawsuit",
      "id": 134381639,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb (BMY) and three US-based units of Sanofi (SNY) have reached a settlement for $7",
      "url": "https://finnhub.io/api/news?id=51f948df25d03f54d6223f156bd21005750d3daf53a4b718c338fd053609a55e"
    }
  },
  {
    "ts": null,
    "headline": "Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet",
    "summary": "Trump aims to cut US drug prices by 30-80% via Executive Order. Check out how pharma companies could be affected and how this may play out in the future.",
    "url": "https://finnhub.io/api/news?id=f3bdfb278b3d923fb7ecd9a0eb0a6ca51ad748153503c12329641a35d2d60c57",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747053003,
      "headline": "Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet",
      "id": 134386076,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1756275584/image_1756275584.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Trump aims to cut US drug prices by 30-80% via Executive Order. Check out how pharma companies could be affected and how this may play out in the future.",
      "url": "https://finnhub.io/api/news?id=f3bdfb278b3d923fb7ecd9a0eb0a6ca51ad748153503c12329641a35d2d60c57"
    }
  },
  {
    "ts": null,
    "headline": "Trump’s Vow to Cut US Drug Prices Drags Pharma Stocks Lower",
    "summary": "(Bloomberg) -- President Donald Trump said he plans to order a cut in US prescription drug costs to bring them in line with other countries, spurring a drop in pharmaceutical shares worldwide.Most Read from BloombergA New Central Park Amenity, Tailored to Its East Harlem NeighborsAs Trump Reshapes Housing Policy, Renters Face Rollback of RightsWhat’s Behind the Rise in Serious Injuries on New York City’s Streets?Is Trump’s Plan to Reopen the Notorious Alcatraz Prison Realistic?NYC Warns of 17% D",
    "url": "https://finnhub.io/api/news?id=0ed68ac2f804ddcc0a1868fcbb1408e4d02677fcb05f84f561f6989bfb263898",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747049896,
      "headline": "Trump’s Vow to Cut US Drug Prices Drags Pharma Stocks Lower",
      "id": 134379232,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "(Bloomberg) -- President Donald Trump said he plans to order a cut in US prescription drug costs to bring them in line with other countries, spurring a drop in pharmaceutical shares worldwide.Most Read from BloombergA New Central Park Amenity, Tailored to Its East Harlem NeighborsAs Trump Reshapes Housing Policy, Renters Face Rollback of RightsWhat’s Behind the Rise in Serious Injuries on New York City’s Streets?Is Trump’s Plan to Reopen the Notorious Alcatraz Prison Realistic?NYC Warns of 17% D",
      "url": "https://finnhub.io/api/news?id=0ed68ac2f804ddcc0a1868fcbb1408e4d02677fcb05f84f561f6989bfb263898"
    }
  },
  {
    "ts": null,
    "headline": "BMY Q1 Earnings Call: Growth Portfolio Offsets Declines, Guidance Raised Amid Pipeline Advancements",
    "summary": "Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 5.6% year on year to $11.2 billion. The company’s full-year revenue guidance of $46.3 billion at the midpoint came in 1.2% above analysts’ estimates. Its non-GAAP profit of $1.80 per share was 19.8% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=232ea5f1f4831d36e9d4d9126adeabe799194ae28836dc4a71a54596d1b56129",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747043965,
      "headline": "BMY Q1 Earnings Call: Growth Portfolio Offsets Declines, Guidance Raised Amid Pipeline Advancements",
      "id": 134379502,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 5.6% year on year to $11.2 billion. The company’s full-year revenue guidance of $46.3 billion at the midpoint came in 1.2% above analysts’ estimates. Its non-GAAP profit of $1.80 per share was 19.8% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=232ea5f1f4831d36e9d4d9126adeabe799194ae28836dc4a71a54596d1b56129"
    }
  },
  {
    "ts": null,
    "headline": "Trump calls for broad drug price cuts in executive order",
    "summary": "U.S. President DonaldTrump plans to sign a wide-reaching executive order on Mondaydirecting drugmakers to lower the prices of their medicines toalign with what other countries pay. ...",
    "url": "https://finnhub.io/api/news?id=7cfd086d36c5500ce580b9652dec2ed09d5401a18a01bc6fd02f732aaea9ec46",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747042790,
      "headline": "Trump calls for broad drug price cuts in executive order",
      "id": 134378934,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "U.S. President DonaldTrump plans to sign a wide-reaching executive order on Mondaydirecting drugmakers to lower the prices of their medicines toalign with what other countries pay. ...",
      "url": "https://finnhub.io/api/news?id=7cfd086d36c5500ce580b9652dec2ed09d5401a18a01bc6fd02f732aaea9ec46"
    }
  },
  {
    "ts": null,
    "headline": "Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices",
    "summary": "(Bloomberg) -- Shares of pharmaceutical companies fell across the world after US President Donald Trump said he planned to order a cut in US prescription drug costs to bring them in line with other countries, prompting concern that profits will take a hit.Most Read from BloombergA New Central Park Amenity, Tailored to Its East Harlem NeighborsAs Trump Reshapes Housing Policy, Renters Face Rollback of RightsWhat’s Behind the Rise in Serious Injuries on New York City’s Streets?Is Trump’s Plan to R",
    "url": "https://finnhub.io/api/news?id=803a34c4b75b272c31602fdb892079821fd3c2013e3b55a564d6bf5776762dd1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747038493,
      "headline": "Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices",
      "id": 134379236,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "(Bloomberg) -- Shares of pharmaceutical companies fell across the world after US President Donald Trump said he planned to order a cut in US prescription drug costs to bring them in line with other countries, prompting concern that profits will take a hit.Most Read from BloombergA New Central Park Amenity, Tailored to Its East Harlem NeighborsAs Trump Reshapes Housing Policy, Renters Face Rollback of RightsWhat’s Behind the Rise in Serious Injuries on New York City’s Streets?Is Trump’s Plan to R",
      "url": "https://finnhub.io/api/news?id=803a34c4b75b272c31602fdb892079821fd3c2013e3b55a564d6bf5776762dd1"
    }
  },
  {
    "ts": null,
    "headline": "Trump to sign drug pricing executive order, promises 59% cut",
    "summary": "U.S. President DonaldTrump plans to sign an executive order on prescription drugpricing on Monday that aims to align the United States with whatother countries pay, a move he said on social media...",
    "url": "https://finnhub.io/api/news?id=9fd87dfb7589fbd03d173496037983948e8a20806c823ade440778695e26e138",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747036677,
      "headline": "Trump to sign drug pricing executive order, promises 59% cut",
      "id": 134377898,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "U.S. President DonaldTrump plans to sign an executive order on prescription drugpricing on Monday that aims to align the United States with whatother countries pay, a move he said on social media...",
      "url": "https://finnhub.io/api/news?id=9fd87dfb7589fbd03d173496037983948e8a20806c823ade440778695e26e138"
    }
  },
  {
    "ts": null,
    "headline": "Trump Renews Push for Most-Favored-Nation Drug Pricing. What It All Means.",
    "summary": "Trump Renews Push for Most-Favored-Nation Drug Pricing. What It All Means.",
    "url": "https://finnhub.io/api/news?id=2f17615fa3dc3229d7cead908effa15fa28091274631f5b10eb144d739354714",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747013400,
      "headline": "Trump Renews Push for Most-Favored-Nation Drug Pricing. What It All Means.",
      "id": 134382838,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Trump Renews Push for Most-Favored-Nation Drug Pricing. What It All Means.",
      "url": "https://finnhub.io/api/news?id=2f17615fa3dc3229d7cead908effa15fa28091274631f5b10eb144d739354714"
    }
  },
  {
    "ts": null,
    "headline": "High-Quality Dividend Growth Stocks Near 52-Week Lows: Alphabet Is Astounding",
    "summary": "A list of high-quality dividend-growth stocks trading near 52-week lows is evaluated. Read what makes GOOG stock is a compelling investment.",
    "url": "https://finnhub.io/api/news?id=271defdcaa1d7c4f740989245dac0be0fae96377b5585e7fe2fa2cba60148ce3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747013223,
      "headline": "High-Quality Dividend Growth Stocks Near 52-Week Lows: Alphabet Is Astounding",
      "id": 134374993,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1400200369/image_1400200369.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "A list of high-quality dividend-growth stocks trading near 52-week lows is evaluated. Read what makes GOOG stock is a compelling investment.",
      "url": "https://finnhub.io/api/news?id=271defdcaa1d7c4f740989245dac0be0fae96377b5585e7fe2fa2cba60148ce3"
    }
  },
  {
    "ts": null,
    "headline": "SCHD: There Are Better Flight To Safety Plays Out There",
    "summary": "SCHD has been seeing renewed popularity amid this yearâs turbulent market. Read why SCHD ETF is not quite the safe haven it appears to be.",
    "url": "https://finnhub.io/api/news?id=6142a0948cebc7e4289153424982ac5bdbbea3166a97fad3e32fcb2cea38a44b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747010391,
      "headline": "SCHD: There Are Better Flight To Safety Plays Out There",
      "id": 134374697,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2190227175/image_2190227175.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "SCHD has been seeing renewed popularity amid this yearâs turbulent market. Read why SCHD ETF is not quite the safe haven it appears to be.",
      "url": "https://finnhub.io/api/news?id=6142a0948cebc7e4289153424982ac5bdbbea3166a97fad3e32fcb2cea38a44b"
    }
  }
]